卡贝戈林在治疗巨症中的实际价值
1Institute of Endocrinology, Rabin Medical Centre, Beilinson Hospital, Petach Tikva, and School of Medicine, Tel-Aviv University, Israel.
卡伯戈林是一种多巴胺激动剂,为壮症提供了一种方便的口服治疗方法. 它有效地使约三分之一的患者的IGF-1水平正常化,特别是那些初始升高较轻的患者.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 卡伯戈林是一种多巴胺受体2 (DR2) 激动剂,用于治疗益生菌瘤和帕金森病.
- 在体腺瘤中存在DR2,这使得卡贝戈林成为壮症的潜在治疗方法.
研究的目的:
- 评估卡伯戈林在治疗壮病中的功效和作用.
- 为了确定在壮病患者中对卡伯戈林治疗的反应的预测因素.
主要方法:
- 卡伯戈林 (Cabergoline) 用于口服,作为单疗法或补充治疗.
- 评估胰岛素类生长因子-1 (IGF-1) 的正常化和生长激素 (GH) 水平.
- 基线IGF-1水平作为缓解的预测指标的分析.
主要成果:
- 卡伯戈林在约三分之一的壮病患者中实现了IGF-1正常化.
- 较低的IGF-1基线水平 (低于1.5xULN) 预测了成功的缓解.
- 卡伯戈林可以作为单一疗法使用,也可以与其他疗法结合使用,如索马托斯塔丁类似物或佩格维索曼特.
结论:
- 卡伯戈林是一种有吸引力的,耐受良好的,且具有成本效益的口服疗法,用于治疗活跃的巨.
- 它的实用性在手术后或作为附加治疗的轻度GH/IGF-1升高患者中显著.
- 预测因素,如基线IGF-1水平,可以指导治疗决策.
更多相关视频
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
